GPC3 and hepatocellular carcinoma: Li et al. constructed bispecific GPC3 and PD-1 CAR T cells that demonstrated sustained toxicity against PD-L1+ HCC cells in vitro and induced tumor suppression, and extended survival in PD-L1+ HCC xenograft murine models, as opposed to their single-target counterparts [167].